Mylan names 2 to board

  • February 11, 2013

CANONSBURG (AP) — Mylan Inc. said Monday that it has added two new members to its board of directors, expanding it to 13 members.

The pharmaceutical company’s board appointed Melina Higgins, a former partner at Goldman, Sachs & Co., and Rajiv Malik, Mylan’s president, to the board.

Higgins joined Goldman Sachs in 1989 and retired in 2010 after serving as a partner and in various leadership roles.

Malik has held important leadership positions at Mylan since January 2007, when the company acquired a controlling stake in Matrix Laboratories Ltd., now Mylan Laboratories Ltd. Malik was the CEO of the active pharmaceutical ingredients supplier.

Mylan Executive Chairman Robert J. Coury said the appointments deliver on the company’s objective of strengthening Mylan at all levels.

Mylan markets the EpiPen, an epinephrine auto-injector for treating severe allergic reactions. Pfizer Inc. makes EpiPen, and Mylan markets it in the U.S. Mylan also makes generic and specialty prescription drugs.


blog comments powered by Disqus

Warner opens up about Cosby allegations

Widow of musician Frank Zappa dies at 70

‘Rock Band’ mounts a raucous reunion tour

Pop star Selena Gomez has gotten chemotherapy to treat lupus

At age 12, a second Broadway role awaits Pizzolo

‘Jay Leno’s Garage’ rolls into prime-time on CNBC

Belgian director Chantal Akerman dies at 65

Pop, country singer Billy Joe Royal dies at age 73

Actor Randy Quaid detained ahead of immigration hearing

‘The 39 Steps’